Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ardelyx Net Income 2013-2024 | ARDX

Ardelyx net income from 2013 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  
Ardelyx Annual Net Income
(Millions of US $)
2023 $-66
2022 $-67
2021 $-158
2020 $-94
2019 $-95
2018 $-91
2017 $-64
2016 $-112
2015 $-30
2014 $-3
2013 $-7
2012 $-10
Ardelyx Quarterly Net Income
(Millions of US $)
2024-03-31 $-27
2023-12-31 $-29
2023-09-30 $7
2023-06-30 $-17
2023-03-31 $-27
2022-12-31 $11
2022-09-30 $-23
2022-06-30 $-27
2022-03-31 $-28
2021-12-31 $-36
2021-09-30 $-44
2021-06-30 $-45
2021-03-31 $-33
2020-12-31 $-29
2020-09-30 $-18
2020-06-30 $-25
2020-03-31 $-22
2019-12-31 $-20
2019-09-30 $-24
2019-06-30 $-25
2019-03-31 $-26
2018-12-31 $-28
2018-09-30 $-24
2018-06-30 $-22
2018-03-31 $-17
2017-12-31 $10
2017-09-30 $-21
2017-06-30 $-26
2017-03-31 $-28
2016-12-31 $-31
2016-09-30 $-29
2016-06-30 $-29
2016-03-31 $-23
2015-12-31 $-17
2015-09-30 $-18
2015-06-30 $9
2015-03-31 $-4
2014-12-31 $-1
2014-09-30 $0
2014-06-30 $1
2014-03-31 $-3
2013-12-31 $-4
2013-09-30 $-1
2013-06-30 $-1
2013-03-31 $-0
2012-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.510B $0.124B
Ardelyx, Inc. is a clinical-stage biopharmaceutical company. It discovers, develops and commercializes small molecule therapeutics that work in the gastrointestinal tract to treat cardio-renal, GI and metabolic diseases. The Company's lead product candidate is Tenapanor which is in three ongoing Phase II clinical trials for the treatment of patients with ESRD-HD and chronic kidney disease, as well as for constipation-predominant irritable bowel syndrome. Ardelyx, Inc. is headquartered in Fremont, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.172B 31.78
Chugai Pharmaceutical (CHGCY) Japan $51.850B 23.18
Takeda Pharmaceutical (TAK) Japan $41.396B 8.38
Merck (MKGAF) Germany $24.039B 23.31
Astellas Pharma (ALPMY) Japan $17.355B 27.40
Sandoz Group AG (SDZNY) Switzerland $15.585B 0.00
Neurocrine Biosciences (NBIX) United States $13.713B 37.54
United Therapeutics (UTHR) United States $12.756B 13.60
Shionogi (SGIOY) Japan $11.328B 9.85
Catalent (CTLT) United States $10.129B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.577B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.105B 7.81
Revolution Medicines (RVMD) United States $6.557B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Ionis Pharmaceuticals (IONS) United States $6.002B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.904B 0.00
Summit Therapeutics (SMMT) United States $5.679B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.698B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.291B 0.00
Corcept Therapeutics (CORT) United States $3.281B 29.73
Dyne Therapeutics (DYN) United States $2.944B 0.00
PTC Therapeutics (PTCT) United States $2.830B 0.00
Indivior (INDV) United States $2.246B 10.65
Recursion Pharmaceuticals (RXRX) United States $2.244B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.161B 12.28
Catalyst Pharmaceuticals (CPRX) United States $1.811B 17.62
NewAmsterdam Pharma (NAMS) Netherlands $1.749B 0.00
Evotec AG (EVO) Germany $1.616B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.606B 24.15
Avadel Pharmaceuticals (AVDL) Ireland $1.527B 0.00
Soleno Therapeutics (SLNO) United States $1.504B 0.00
Pacira BioSciences (PCRX) United States $1.321B 12.55
Xencor (XNCR) United States $1.314B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.286B 0.00
4D Molecular Therapeutics (FDMT) United States $1.262B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.164B 0.00
Collegium Pharmaceutical (COLL) United States $1.045B 6.25
Relay Therapeutics (RLAY) United States $1.039B 0.00
Enliven Therapeutics (ELVN) United States $1.036B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.998B 0.00
Cassava Sciences (SAVA) United States $0.954B 0.00
Cronos Group (CRON) Canada $0.940B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.936B 14.59
ARS Pharmaceuticals (SPRY) United States $0.866B 0.00
USANA Health Sciences (USNA) United States $0.865B 14.14
Ocular Therapeutix (OCUL) United States $0.781B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.763B 0.00
Sage Therapeutics (SAGE) United States $0.692B 0.00
ProKidney (PROK) United States $0.681B 0.00
Lyell Immunopharma (LYEL) United States $0.660B 0.00
Harrow (HROW) United States $0.635B 0.00
Larimar Therapeutics (LRMR) United States $0.618B 0.00
Lexeo Therapeutics (LXEO) United States $0.618B 0.00
Silence Therapeutics (SLN) United Kingdom $0.590B 0.00
Exscientia (EXAI) United Kingdom $0.575B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.565B 0.00
Savara (SVRA) United States $0.561B 0.00
Esperion Therapeutics (ESPR) United States $0.551B 0.00
Heron Therapeutics (HRTX) United States $0.548B 0.00
Siga Technologies (SIGA) United States $0.537B 6.86
Bioventus (BVS) United States $0.518B 19.82
KalVista Pharmaceuticals (KALV) United States $0.517B 0.00
OmniAb (OABI) United States $0.496B 0.00
Verve Therapeutics (VERV) United States $0.470B 0.00
Altimmune (ALT) United States $0.469B 0.00
Tourmaline Bio (TRML) United States $0.426B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.417B 0.00
Korro Bio (KRRO) United States $0.394B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.363B 0.00
Black Diamond Therapeutics (BDTX) United States $0.347B 0.00
Organogenesis (ORGO) United States $0.346B 65.25
Xeris Biopharma Holdings (XERS) United States $0.329B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.284B 0.00
Fractyl Health (GUTS) United States $0.284B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.87
Century Therapeutics (IPSC) United States $0.270B 0.00
Eliem Therapeutics (ELYM) United States $0.259B 0.00
Aquestive Therapeutics (AQST) United States $0.252B 0.00
Nanobiotix S.A (NBTX) France $0.252B 0.00
Foghorn Therapeutics (FHTX) United States $0.239B 0.00
Acrivon Therapeutics (ACRV) United States $0.238B 0.00
Akebia Therapeutics (AKBA) United States $0.235B 0.00
Pyxis Oncology (PYXS) United States $0.233B 0.00
Nektar Therapeutics (NKTR) United States $0.230B 0.00
Aldeyra Therapeutics (ALDX) United States $0.229B 0.00
Metagenomi (MGX) United States $0.225B 0.00
Avita Medical (RCEL) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.217B 0.00
Prelude Therapeutics (PRLD) United States $0.214B 0.00
Zevra Therapeutics (ZVRA) United States $0.206B 0.00
ESSA Pharma (EPIX) Canada $0.205B 0.00
Incannex Healthcare (IXHL) Australia $0.200B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Adherex Technologies (FENC) United States $0.188B 229.33
Elite Pharmaceuticals (ELTP) United States $0.180B 16.84
Achieve Life Sciences (ACHV) Canada $0.175B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.171B 0.00
Telomir Pharmaceuticals (TELO) United States $0.167B 0.00
Galectin Therapeutics (GALT) United States $0.165B 0.00
Regulus Therapeutics (RGLS) United States $0.162B 0.00
Cardiol Therapeutics (CRDL) Canada $0.161B 0.00
Conduit Pharmaceuticals (CDT) United States $0.149B 0.00
Context Therapeutics (CNTX) United States $0.148B 0.00
MediWound (MDWD) Israel $0.145B 0.00
CytoDyn (CYDY) United States $0.136B 0.00
OptiNose (OPTN) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.133B 0.00
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
FibroGen (FGEN) United States $0.115B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.114B 7.64
Citius Pharmaceuticals (CTXR) United States $0.113B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Assertio Holdings (ASRT) United States $0.099B 4.52
Relmada Therapeutics (RLMD) United States $0.091B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
Vivani Medical (VANI) United States $0.089B 0.00
ProPhase Labs (PRPH) United States $0.089B 0.00
AlloVir (ALVR) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
SCYNEXIS (SCYX) United States $0.080B 1.13
Marinus Pharmaceuticals (MRNS) United States $0.080B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Tempest Therapeutics (TPST) United States $0.067B 0.00
Nutriband (NTRB) United States $0.066B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.057B 0.00
Mural Oncology (MURA) Ireland $0.056B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Protara Therapeutics (TARA) United States $0.054B 0.00
DURECT (DRRX) United States $0.052B 0.00
Carisma Therapeutics (CARM) United States $0.049B 0.00
Inotiv (NOTV) United States $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
NRx Pharmaceuticals (NRXP) United States $0.037B 0.00
Rafael Holdings (RFL) United States $0.036B 0.00
Surrozen (SRZN) United States $0.036B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.036B 0.00
Gain Therapeutics (GANX) United States $0.034B 0.00
VYNE Therapeutics (VYNE) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Viracta Therapeutics (VIRX) United States $0.025B 0.00
Unicycive Therapeutics (UNCY) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
SHINECO (SISI) China $0.024B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
Minerva Neurosciences (NERV) United States $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
JanOne (JAN) United States $0.022B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Lyra Therapeutics (LYRA) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Talphera (TLPH) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Alaunos Therapeutics (TCRT) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
Ainos (AIMD) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.94
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.02